Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Biodefense market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Biodefense market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Biodefense market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Biodefense products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Biodefense products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Biodefense market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Biodefense development has been the leading industry trend of Biodefense market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Biodefense Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Anthrax,Smallpox,Botulism,Radiation/Nuclear,Others |
| By Application Outlook |
US Military Market,US Civilian Market,Non - US Market, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Emergent Biosolutions,Hytest,GSK,Sanofi,PharmAthene,Bavarian Nordic,SIGA Technologies,Arbutus Biopharma,DynPort Vaccine,Xoma Corporation,Ichor Medical Systems,Aeolus Pharmaceuticals,Achaogen,Elusys Therapeutics,Dynavax Technologies,Cleveland BioLabs,Soligenix,Alnylam Pharmaceuticals |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
Biodefense Market, By Type
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
Biodefense Market, By Application
- US Military Market
- US Civilian Market
- Non - US Market
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Biodefense Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Biodefense Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Biodefense Industry Overview
2.1 Global Biodefense Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Biodefense Global Import Market Analysis
2.1.2 Biodefense Global Export Market Analysis
2.1.3 Biodefense Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3.2 US Civilian Market
2.3.3 Non - US Market
2.4.2 Global Biodefense Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Biodefense Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Biodefense Manufacturer Market Share
2.4.5 Top 10 Biodefense Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Biodefense Market
2.4.7 Key Manufacturers Biodefense Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Biodefense Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Biodefense Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Biodefense Market Size Categorized by Regions
4.1 Global Biodefense Revenue, Sales and Market Share by Regions
4.1.1 Global Biodefense Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biodefense Revenue and Market Share by Regions (2015-2020)
4.2 Europe Biodefense Sales and Growth Rate (2015-2020)
4.3 APAC Biodefense Sales and Growth Rate (2015-2020)
4.4 North America Biodefense Sales and Growth Rate (2015-2020)
4.5 South America Biodefense Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Biodefense Sales and Growth Rate (2015-2020)
5 Europe Biodefense Market Size Categorized by Countries
5.1 Europe Biodefense Sales, Revenue and Market Share by Countries
5.1.1 Europe Biodefense Sales by Countries (2015-2020)
5.1.2 Europe Biodefense Revenue by Countries (2015-2020)
5.1.3 Germany Biodefense Sales and Growth Rate (2015-2020)
5.1.4 UK Biodefense Sales and Growth Rate (2015-2020)
5.1.5 France Biodefense Sales and Growth Rate (2015-2020)
5.1.6 Russia Biodefense Sales and Growth Rate (2015-2020)
5.1.7 Italy Biodefense Sales and Growth Rate (2015-2020)
5.1.8 Spain Biodefense Sales and Growth Rate (2015-2020)
5.2 Europe Biodefense Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Biodefense Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Biodefense Sales Market Share by Type (2015-2020)
5.3.2 Europe Biodefense Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Biodefense Sales Market Share by Application (2015-2020)
6 Asia-Pacific Biodefense Market Size Categorized by Countries
6.1 Asia-Pacific Biodefense Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Biodefense Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Biodefense Revenue by Countries (2015-2020)
6.1.3 China Biodefense Sales and Growth Rate (2015-2020)
6.1.4 Japan Biodefense Sales and Growth Rate (2015-2020)
6.1.5 Korea Biodefense Sales and Growth Rate (2015-2020)
6.1.6 India Biodefense Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Biodefense Sales and Growth Rate (2015-2020)
6.1.8 Australia Biodefense Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Biodefense Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Biodefense Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Biodefense Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Biodefense Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Biodefense Sales and Market Share by Application (2015-2020)
7 North America Biodefense Market Size Categorized by Countries
7.1 North America Biodefense Sales, Revenue and Market Share by Countries
7.1.1 North America Biodefense Sales by Countries (2015-2020)
7.1.2 North America Biodefense Revenue by Countries (2015-2020)
7.1.3 United States Biodefense Sales and Growth Rate (2015-2020)
7.1.4 Canada Biodefense Sales and Growth Rate (2015-2020)
7.1.5 Mexico Biodefense Sales and Growth Rate (2015-2020)
7.2 North America Biodefense Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Biodefense Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Biodefense Sales Market Share by Type (2015-2020)
7.3.2 North America Biodefense Revenue and Revenue Share by Type (2015-2020)
7.4 North America Biodefense Sales Market Share by Application (2015-2020)
8 South America Biodefense Market Size Categorized by Countries
8.1 South America Biodefense Sales, Revenue and Market Share by Countries
8.1.1 South America Biodefense Sales by Countries (2015-2020)
8.1.2 South America Biodefense Revenue by Countries (2015-2020)
8.1.3 Brazil Biodefense Sales and Growth Rate (2015-2020)
8.2 South America Biodefense Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Biodefense Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Biodefense Sales Market Share by Type (2015-2020)
8.3.2 South America Biodefense Revenue and Revenue Share by Type (2015-2020)
8.4 South America Biodefense Sales Market Share by Application (2015-2020)
9 Middle East and Africa Biodefense Market Size Categorized by Countries
9.1 Middle East and Africa Biodefense Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biodefense Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Biodefense Revenue by Countries (2015-2020)
9.1.3 GCC Countries Biodefense Sales and Growth Rate (2015-2020)
9.1.4 Turkey Biodefense Sales and Growth Rate (2015-2020)
9.1.5 Egypt Biodefense Sales and Growth Rate (2015-2020)
9.1.6 South Africa Biodefense Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Biodefense Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Biodefense Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Biodefense Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Biodefense Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Biodefense Sales Market Share by Application (2015-2020)
10 Global Biodefense Market Segment by Type
10.1 Global Biodefense Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Biodefense Sales and Market Share by Type (2015-2020)
10.1.2 Global Biodefense Revenue and Market Share by Type (2015-2020)
10.2 Anthrax Sales Growth Rate and Price
10.2.1 Global Anthrax Sales Growth Rate (2015-2020)
10.2.2 Global Anthrax Price (2015-2020)
10.3 Smallpox Sales Growth Rate and Price
10.3.1 Global Smallpox Sales Growth Rate (2015-2020)
10.3.2 Global Smallpox Price (2015-2020)
10.4 Botulism Sales Growth Rate and Price
10.4.1 Global Botulism Sales Growth Rate (2015-2020)
10.4.2 Global Botulism Price (2015-2020)
10.5 Radiation/Nuclear Sales Growth Rate and Price
10.5.1 Global Radiation/Nuclear Sales Growth Rate (2015-2020)
10.5.2 Global Radiation/Nuclear Price (2015-2020)
10.6 Others Sales Growth Rate and Price
10.6.1 Global Others Sales Growth Rate (2015-2020)
10.6.2 Global Others Price (2015-2020)
11.1 Global BiodefenseSales Market Share by Application (2015-2020)
11.2 US Military Market Sales Growth Rate (2015-2020)
11.3 US Civilian Market Sales Growth Rate (2015-2020)
11.4 Non - US Market Sales Growth Rate (2015-2020)
12.1 Global Biodefense Revenue, Sales and Growth Rate (2020-2027)
12.2 Biodefense Market Forecast by Regions (2020-2027)
12.2.1 Europe Biodefense Market Forecast (2020-2027)
12.2.2 APAC Biodefense Market Forecast (2020-2027)
12.2.3 North America Biodefense Market Forecast (2020-2027)
12.2.4 South America Biodefense Market Forecast (2020-2027)
12.2.5 Middle East & Africa Biodefense Market Forecast (2020-2027)
12.3 Biodefense Market Forecast by Type (2020-2027)
12.3.1 Global Biodefense Sales Forecast by Type (2020-2027)
12.3.2 Global Biodefense Market Share Forecast by Type (2020-2027)
12.4 Biodefense Market Forecast by Application (2020-2027)
12.4.1 Global Biodefense Sales Forecast by Application (2020-2027)
12.4.2 Global Biodefense Market Share Forecast by Application (2020-2027)
13 Analysis of Biodefense Industry Key Manufacturers
13.1 Emergent Biosolutions
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Emergent Biosolutions Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Emergent Biosolutions News
13.2 Hytest
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Hytest Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Hytest News
13.3 GSK
13.3.1 Company Details
13.3.2 Product Information
13.3.3 GSK Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 GSK News
13.4 Sanofi
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Sanofi Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Sanofi News
13.5 PharmAthene
13.5.1 Company Details
13.5.2 Product Information
13.5.3 PharmAthene Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 PharmAthene News
13.6 Bavarian Nordic
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Bavarian Nordic Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Bavarian Nordic News
13.7 SIGA Technologies
13.7.1 Company Details
13.7.2 Product Information
13.7.3 SIGA Technologies Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 SIGA Technologies News
13.8 Arbutus Biopharma
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Arbutus Biopharma Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Arbutus Biopharma News
13.9 DynPort Vaccine
13.9.1 Company Details
13.9.2 Product Information
13.9.3 DynPort Vaccine Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 DynPort Vaccine News
13.10 Xoma Corporation
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Xoma Corporation Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Xoma Corporation News
13.11 Ichor Medical Systems
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Ichor Medical Systems Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Ichor Medical Systems News
13.12 Aeolus Pharmaceuticals
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Aeolus Pharmaceuticals Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Aeolus Pharmaceuticals News
13.13 Achaogen
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Achaogen Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Achaogen News
13.14 Elusys Therapeutics
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Elusys Therapeutics Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Elusys Therapeutics News
13.15 Dynavax Technologies
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Dynavax Technologies Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Dynavax Technologies News
13.16 Cleveland BioLabs
13.16.1 Company Details
13.16.2 Product Information
13.16.3 Cleveland BioLabs Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.16.4 Main Business Overview
13.16.5 Cleveland BioLabs News
13.17 Soligenix
13.17.1 Company Details
13.17.2 Product Information
13.17.3 Soligenix Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.17.4 Main Business Overview
13.17.5 Soligenix News
13.18 Alnylam Pharmaceuticals
13.18.1 Company Details
13.18.2 Product Information
13.18.3 Alnylam Pharmaceuticals Biodefense Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.18.4 Main Business Overview
13.18.5 Alnylam Pharmaceuticals News
15 Appendix
